L-theanine turns up in sleep formulas next to melatonin and valerian, which sets an expectation the research does not support. The trials that exist measured something narrower and more interesting than sedation, and a fair reading has to include the outcome that did not move.
Isolated from green tea in 1949
Japanese researchers working on what gives high-grade green tea its savoury character identified an amino acid that had not been described before. Yajiro Sakato named it theanine in 1949.
It is unusual twice over: it is a non-protein amino acid, meaning it is not built into human proteins, and it is almost entirely confined to the tea plant and a small number of fungi.
Theanine makes up a substantial share of the free amino acids in tea leaf, which is why the compound and the drink are so often discussed as if they were interchangeable. They are not, and the arithmetic on that appears further down.
Why it is not a sedative
The mechanism is a different one
A sedative works by amplifying inhibitory signalling, typically at the GABA-A receptor. That is the mechanism behind benzodiazepines and the "z-drugs", and it is what produces sleep onset, next-day grogginess, tolerance and dependence.
Theanine does not act there. It is a structural relative of glutamate and glutamine, and the mechanisms proposed for it involve weak interaction with glutamate receptor systems rather than potentiation of inhibition.
It is not melatonin either
Melatonin is a hormone, and it acts on the timing of the sleep-wake cycle rather than on sedation — which is why it is studied for shifted schedules and jet lag. Theanine has no comparable circadian role.
Three mechanisms — sedation, circadian timing and whatever theanine does — sold side by side on one shelf is a fair summary of the sleep aisle.
Which sets up the whole difficulty with this ingredient. Something that is not a sedative can still show up in sleep measurements, but not through the door most people assume.
The alpha-wave result, at its real weight
The most-quoted finding is that theanine increases alpha activity on EEG. In a report on healthy adults given 50 mg, alpha-band activity rose in a relaxed but alert state (Nobre, Rao and Owen, Asia Pacific Journal of Clinical Nutrition, 2008; n=35, single dose). Whether 200 mg produces the same EEG pattern, a larger one or a different one has not been tested at comparable resolution — and the studies that follow all used the higher dose.
Two honest qualifications. That was published as a short report in a conference supplement, not as a full paper — a weaker publication format than the citation count implies.
And alpha activity is a correlate of relaxed wakefulness. It is the signature of sitting quietly with the eyes closed, which is close to the opposite of the deep-sleep EEG signature.
The pharmacokinetics constrain what it can be
After an oral dose, theanine appears in blood quickly — peak concentrations at roughly 50 minutes — and clears with a half-life on the order of an hour (van der Pijl et al., Journal of Functional Foods, 2010; n=6 healthy adults, doses of 25 to 200 mg).
Nothing with that profile accumulates, which means any sustained effect would need a different explanation — and none has been demonstrated here.
That single fact separates it from most of the shelf, and the general version of the argument is in how long a supplement actually takes.
What has been measured about sleep
Six weeks, actigraphy, and a mixed result
Boys aged 8 to 12 with diagnosed ADHD took 200 mg twice daily for six weeks, with sleep recorded by wrist actigraphy. Sleep percentage and sleep efficiency increased against placebo. Sleep-onset latency did not change (Lyon, Kapoor and Juneja, Alternative Medicine Review, 2011; n=98, randomised double-blind).
That is the most informative single result in the literature, and the part usually left out of the summary is what did not move.
Four weeks, questionnaire, healthy adults
Healthy adults took 200 mg a day for four weeks. Scores on sleep latency, sleep disturbance and use of sleep medication within the Pittsburgh Sleep Quality Index improved against placebo (Hidese et al., Nutrients, 2019; n=30, randomised placebo-controlled crossover).
Thirty people, four weeks, self-report. Worth having and not worth over-reading.
The trials, side by side
| Study | Who | Dose and duration | How sleep was measured | Result |
|---|---|---|---|---|
| Lyon et al., 2011 | n=98, boys aged 8–12 with ADHD | 400 mg/day, six weeks | Wrist actigraphy | Sleep efficiency up; sleep-onset latency unchanged |
| Hidese et al., 2019 | n=30, healthy adults | 200 mg/day, four weeks | Pittsburgh Sleep Quality Index | Latency, disturbance and medication-use subscores improved |
| Nobre et al., 2008 | n=35, healthy adults | 50 mg, single dose | EEG, awake | Alpha activity increased; sleep not measured |
What that pattern says
Read together, the measurements point at sleep quality rather than sleep onset — how settled the night was, not how fast it started.
Which is consistent with a compound that reduces arousal without inducing sleep. It is also a much smaller claim than the shelf placement suggests, and it is the claim the data supports.
There is a second point here, and it is the part a label will not print. Nothing in this literature shows by an objective measure that theanine shortens the time taken to fall asleep: the one trial that measured onset with actigraphy was in children and found no change, and the adult result is a questionnaire subscore.
Where the evidence is thin
Nobody has run the obvious trial
There is no large polysomnography study of theanine in adults with diagnosed insomnia. Actigraphy and questionnaires are what exist, and both are proxies.
The samples are small and the durations short
Thirty people for four weeks, ninety-eight children for six. Nothing here has been tested for a year in the population that buys it.
Much of it is funded by the ingredient supplier
Several of the trials, including the 2011 actigraphy study, include authors affiliated with the manufacturer of a branded theanine ingredient. That does not make a result wrong, and it is a fact a reader is entitled to have.
A cup of tea is not a dose
Analyses of brewed commercial teas put theanine content per cup in the single to low double digits of milligrams (Boros et al., Pharmacognosy Magazine, 2016; laboratory analysis of commercial tea infusions).
The trials above used 200 to 400 mg a day. Reaching that through tea would mean a quantity of caffeine nobody would recommend before bed, which is the practical reason the compound is sold separately from the leaf.
The negative results, stated
A systematic review of theanine and stress concluded that effects were most consistent at 200 to 400 mg in acute stressful conditions, and that the evidence was insufficient to support use for chronic anxiety (Williams et al., Plant Foods for Human Nutrition, 2020; systematic review).
In the four-week trial in healthy adults, cognitive outcomes were not uniformly improved — the clearer differences appeared in a subgroup rather than across the whole sample (Hidese et al., 2019; n=30).
A compound with a genuine acute effect and thin chronic evidence is a specific and unglamorous thing, and it is what the record here describes.
Why it sits in a daytime formula
The best-replicated theanine results are not about sleep at all. They come from the pairing with caffeine, where combined-dose studies have measured attention-task performance — reviewed with their effect sizes in why L-theanine and caffeine are so often taken together.
Since it clears within hours and does not accumulate, when it is taken is a live decision rather than a fixed instruction. A formula can state the amount and the timing rationale; it cannot decide for the person holding it whether the calmer afternoon or the calmer evening is the one they want.
How to tell what is in the bottle
Sleep blends frequently bury theanine inside a proprietary mixture, so the amount is unstated and cannot be compared to 200 mg — the specific failure described in what a proprietary blend hides.
Where the amount is printed, the remaining question is what one serving contains; that arithmetic is set out in "Serving size is the number everything else is quoted against".
Where we stand
Weal Focus contains 200 mg of L-theanine, printed as its own line rather than inside a blend, which is the low end of the range used in the published work above.
It is in a daytime formula for the attention-task literature, not as a sleep aid, and this page exists partly to say so. The everyday pattern people describe as losing words mid-sentence is not a sleep complaint either, and conflating the two is how a modest ingredient ends up carrying claims it cannot support. The wider question of which effects arrive in an hour and which take weeks is in how long a supplement actually takes.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Sources for the claims and figures on this page, with the population studied in each, are on our citations page.